Search

The text discusses the decline in HPV vaccination coverage in Japan due to sensationalized reports of adverse reactions in 2013, which led to the government suspending its vaccination program recommendation. Despite the government's efforts to resume active recommendations in 2022, vaccination coverage remains low due to deeply embedded stigma against cervical cancer and the HPV vaccine in Japan. The text suggests introducing an opt-out system for HPV vaccination and disseminating correct information to healthcare professionals as possible solutions to reduce stigma and increase vaccination rates. It also highlights the importance of addressing the stigma surrounding the HPV vaccine in other countries, such as India and Saudi Arabia, to prevent cervical cancer. [Extracted from the article]